← Evidence map

ReviewCancer chemotherapy and pharmacology2022

Anti-cancer drug combinations approved by US FDA from 2011 to 2021: main design features of clinical trials and role of pharmacokinetics.

Salvador Fudio et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

7 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36029310